124 related articles for article (PubMed ID: 35405115)
1. Tasipimidine-the pharmacological profile of a novel orally active selective α
Lehtimäki J; Jalava N; Unkila K; Aspegren J; Haapalinna A; Pesonen U
Eur J Pharmacol; 2022 May; 923():174949. PubMed ID: 35405115
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo profiling of fadolmidine, a novel potent alpha(2)-adrenoceptor agonist with local mode of action.
Lehtimäki J; Leino T; Koivisto A; Viitamaa T; Lehtimäki T; Haapalinna A; Kuokkanen K; Virtanen R
Eur J Pharmacol; 2008 Dec; 599(1-3):65-71. PubMed ID: 18930723
[TBL] [Abstract][Full Text] [Related]
3. The affinity and selectivity of α-adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Apr; 10(2):e00936. PubMed ID: 35224877
[TBL] [Abstract][Full Text] [Related]
4. A study of presynaptic alpha2-autoreceptors in alpha2A/D-, alpha2B- and alpha2C-adrenoceptor-deficient mice.
Trendelenburg AU; Klebroff W; Hein L; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 2001 Aug; 364(2):117-30. PubMed ID: 11534851
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of postsynaptic alpha2-adrenoceptors of the dog mesenteric and rat femoral veins.
Paiva MQ; Morato M; Moura D; Guimarães S
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):165-70. PubMed ID: 10494886
[TBL] [Abstract][Full Text] [Related]
6. Comparison of human alpha1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways.
Taguchi K; Yang M; Goepel M; Michel MC
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):100-10. PubMed ID: 9521482
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of alpha-adrenoceptors that mediate contraction in splenic artery strips from the pig.
Barbieri A; Santagostino-Barbone MG; Zonta F; Lucchelli A
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):654-61. PubMed ID: 9686942
[TBL] [Abstract][Full Text] [Related]
8. The signaling and selectivity of α-adrenoceptor agonists for the human α2A, α2B and α2C-adrenoceptors and comparison with human α1 and β-adrenoceptors.
Proudman RGW; Akinaga J; Baker JG
Pharmacol Res Perspect; 2022 Oct; 10(5):e01003. PubMed ID: 36101495
[TBL] [Abstract][Full Text] [Related]
9. Buspirone functionally discriminates tissues endowed with alpha1-adrenoceptor subtypes A, B, D and L.
Eltze M; König H; Ullrich B; Grebe T
Eur J Pharmacol; 1999 Jul; 378(1):69-83. PubMed ID: 10478567
[TBL] [Abstract][Full Text] [Related]
10. Agonist pharmacology at recombinant α1A - and α1L -adrenoceptors and in lower urinary tract α1 -adrenoceptors.
Yoshiki H; Uwada J; Umada H; Kobayashi T; Takahashi T; Yamakawa T; Yamaguchi A; Yokoyama O; Muramatsu I
Br J Pharmacol; 2013 Nov; 170(6):1242-52. PubMed ID: 24024968
[TBL] [Abstract][Full Text] [Related]
11. Subtypes of functional alpha1- and alpha2-adrenoceptors.
Docherty JR
Eur J Pharmacol; 1998 Nov; 361(1):1-15. PubMed ID: 9851536
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological pleiotropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification.
Ford AP; Daniels DV; Chang DJ; Gever JR; Jasper JR; Lesnick JD; Clarke DE
Br J Pharmacol; 1997 Jul; 121(6):1127-35. PubMed ID: 9249248
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological identification of α1- and α2-adrenoceptor subtypes involved in the vasopressor responses induced by ergotamine in pithed rats.
Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
Eur J Pharmacol; 2013 Sep; 715(1-3):262-9. PubMed ID: 23707349
[TBL] [Abstract][Full Text] [Related]
14. The selectivity of α-adrenoceptor agonists for the human α1A, α1B, and α1D-adrenoceptors.
Proudman RGW; Baker JG
Pharmacol Res Perspect; 2021 Aug; 9(4):e00799. PubMed ID: 34355529
[TBL] [Abstract][Full Text] [Related]
15. [3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin.
Ireland LM; Cain JC; Rotert G; Thomas S; Shoghi S; Hancock AA; Kerwin JF
Eur J Pharmacol; 1997 May; 327(1):79-86. PubMed ID: 9185839
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the subtypes of alpha2-adrenoceptor mediating prejunctional inhibition in rat atrium and cerebral cortex.
Ho SL; Honner V; Docherty JR
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):634-9. PubMed ID: 9686939
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of alpha 2-adrenoceptor-mediated responses in pig nasal mucosa.
Corboz MR; Varty LM; Rizzo CA; Mutter JC; Rivelli MA; Wan Y; Umland S; Qiu H; Jakway J; McCormick KD; Berlin M; Hey JA
Auton Autacoid Pharmacol; 2003 Aug; 23(4):208-19. PubMed ID: 15084187
[TBL] [Abstract][Full Text] [Related]
19. Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology.
Naselsky DP; Ashton D; Ruffolo RR; Hieble JP
J Pharmacol Exp Ther; 2001 Jul; 298(1):219-25. PubMed ID: 11408545
[TBL] [Abstract][Full Text] [Related]
20. Subtype-specific stimulation of [35S]GTPgammaS binding by recombinant alpha2-adrenoceptors.
Peltonen JM; Pihlavisto M; Scheinin M
Eur J Pharmacol; 1998 Aug; 355(2-3):275-9. PubMed ID: 9760042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
